inSoma Bio, Inc.

Biotechnology company · Durham, North Carolina, United States

inSoma Bio, Inc. is a biotechnology company headquartered in Durham, North Carolina, United States. Its earliest recorded incorporation is in 2018. It has received 6 US government small-business research awards (SBIR/STTR) from health agencies, $3.4 million in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $2.7 million sold in a notice filed in 2026.

insomabio.comProfile compiled from public records. Is this your company? Request a correction or update

inSoma Bio at a glance

Typebiotechnology company
HeadquartersDurham, North Carolina, United States
Earliest incorporation on record2018
Employees (per SBIR records)7
SEC CIK1814250

What does inSoma Bio do?

US government research funding

6 SBIR/STTR small-business research awards from US health agencies, $3.4 million in total (2019 to 2024). NIH funding came from the National Cancer Institute, National Institute of General Medical Sciences, National Institute of Diabetes and Digestive and Kidney Diseases.

Private fundraising reported to the SEC

12 Form D notices; the most recent reported $2.7 million sold (2026).

Frequently asked questions about inSoma Bio

Where is inSoma Bio headquartered?

inSoma Bio, Inc. is headquartered in Durham, North Carolina, United States.

What does inSoma Bio do?

inSoma Bio, Inc. is a biotechnology company.

When was inSoma Bio founded?

The earliest incorporation on record for inSoma Bio, Inc. is in 2018, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.

inSoma Bio: Headquarters, Locations & Company Profile (2026) | BioBridgeX